Siemens Healthineers has announced the launch of a centre of excellence for immunoassay research and development (R&D) in Swords that will create 100 jobs, including 65 high-level engineering roles.
The centre will be tasked with making innovations in laboratory instruments used to detect infectious diseases, cancers and blood disorders for the German medical device company, which is part of the wider Siemens group.
The group’s existing manufacturing and engineering site, which supplies medical diagnostic equipment globally, will receive a multi-million-euro investment over several years, and the project is being supported by the government through IDA Ireland.
The positions being filled includes specialised roles in artificial intelligence, machine learning, software engineering, systems engineering and data science. The hiring round will more than double the existing engineering team.
Siemens Healthineers said the investment would create additional jobs and enable clinicians to optimise patient care by bringing new levels of precision, efficiency and reliability to the diagnostic laboratories that serve them.
Congratulating the company on the launch, Taoiseach Leo Varadkar said the new jobs would provide great opportunities for engineers and that the centre was a testament to Ireland’s strong reputation for R&D.
“Exciting new technology like that which will be developed in Swords, can make a real difference to people’s lives, to patient outcomes and to healthcare systems globally,” he added.
Dr Dennis Gilbert, head of R&D for Siemens Healthineers Diagnostics, said: “The investment at Swords will build on our existing expertise in healthcare manufacturing, adding a critical research and development focus.
“Partnering with IDA has enabled us to move forward in ways that would not have otherwise been feasible and will allow us to pioneer breakthroughs in healthcare, helping hospitals and laboratories across the globe to diagnose disease more effectively and efficiently.”
Fred O’Brien, VP of manufacturing and managing director of Swords for Siemens Healthineers, stated: “This is an exciting opportunity for us to create an entrepreneurial research environment, while leveraging the strength and breadth of all that Siemens Healthineers has to offer.
“It highlights the calibre of the existing team and with this investment we will create a hub of skilled and experienced engineers and researchers, broadening the scope of careers in the local area.”
Mary Buckley, interim CEO of IDA, commented: “Today’s investment announcement by Siemens Healthineers is terrific news and demonstrates the company’s continued commitment to Ireland, where it’s had a presence in Dublin for 57 years.”
Siemens Healthineers has been active in Swords supplying medical diagnostic equipment to hospitals and laboratories since 1966.
The site manufactures haematology and immunoassay analysers and supports the continuous innovation of current and new products and the development of laboratory automation software, exported to more than 50 countries across all continents.
Photo: Dr Dennis Gilbert (left), Mary Buckley (second left), Leo Varadkar (centre), and Fred O’Brien (right) at the announcement. (Pic: IDA Ireland)